Corcept Therapeutics (CORT) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $121.05 +1.71%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of $0.32, $0.09 better than the analyst estimate of $0.23. Revenue for the quarter came in at $163.8 million versus the consensus estimate of $155.22 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Blue Moon Metals cleared to build at Nevada tungsten project
- Roots Corporation to go private in C$4.10-per-share deal with Marquee Brands
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
